The Unrestrained Overeating Behavior and Clinical Perspective

Area of Science:

• Neuroscience
• Metabolic Disorders
• Psychiatry

Background:

• Obesity-related comorbidities significantly reduce quality of life and increase mortality risk.
• Binge Eating Disorder (BED) involves excessive food consumption and overeating, correlating with increased morbidity and mortality.
• High-fat diets and sedentary lifestyles contribute to weight gain, insulin resistance, and lipotoxicity through various cellular mechanisms.

Purpose of the Study:

• To explore the complex relationship between food addiction, BED, obesity, and associated comorbidities.
• To review current and potential therapeutic strategies for managing BED and obesity.
• To investigate the neurobiological underpinnings of overnutrition and its effects on hypothalamic pathways.

Main Methods:

• Literature review of studies on BED, obesity, neurobiology, and treatment modalities.
• Analysis of the role of hedonic intake, fat preference, and reward system dysregulation in BED and obesity.
• Examination of cellular and molecular mechanisms involved in lipotoxicity and hypothalamic dysfunction.

Main Results:

• BED is associated with increased sensitivity to palatable foods, leading to obesity and potential insulin resistance.
• Dysregulation in dopaminergic, opioid, and cannabinoid systems contributes to food addiction and BED.
• Pharmacotherapy (opiate receptor antagonists, antidepressants) and neuromodulation (TMS, tDCS) show potential for treating refractory BED and obesity.

Conclusions:

• BED and obesity are complex conditions with significant health consequences, influenced by genetic and environmental factors.
• Integrated treatment approaches combining pharmacotherapy, behavioral management, and potentially neuromodulation are crucial for effective management.
• Further research is needed to elucidate the precise mechanisms linking high-fat diets to hypothalamic dysfunction in obesity.